Medical Journal March 11, 2023

Mavacamten Alters SCD Risk Scores, Not Outcomes

Data show marker improvement with mavacamten in obstructive HCM, but reclassification isn’t the same as proven mortality benefit — randomized or long-term outcome studies are still needed.

Age-Specific Needs in Young Women With Breast Cancer

Drs Olivia Pagani and Ann Partridge discuss how to optimize the care plan for young patients with breast cancer, focusing on age-specific concerns such as fertility and long-term survivorship.

Amantadine Awakens 94-Year-Old Woman After Stroke

A short amantadine course produced eye opening and tracking within 24 hours and a GCS of 14-15 by day 4 in a case of prolonged nontraumatic impaired consciousness.

Advances in Chronic Rhinosinusitis From ARS 2026

Advances in chronic rhinosinusitis from ARS 2026 include data on biologics vs surgery rates, AI tools in clinic, and wearable tech to document clinical efficacy, as reported by Dr Vijay Ramakrishnan.

Anticipating Key Early Breast Cancer Research at ASCO 2026

Dr Bora Lim anticipates new data on bispecific antibodies and CDK4 inhibitors, as well as crucial updates on ADCs and ctDNA-guided treatments.

May 15 2026 This Week in Cardiology

Another positive digoxin trial, another classic coronary physiology study from Imperial College London (ORBITA-FIRE), news in hypertrophic cardiomyopathy, and TAVR done in the wrong patients are the topics John Mandrola, MD, discusses in this week’s podcast.

Inside OCT and IVUS: AI’s New Edge in PCI

From automatic calcium and lipid detection to post-stent expansion checks, learn how AI helps close the gap between novice and expert and why that matters for outcomes.

Therapeutic Advances in Immune Thrombocytopenia: Patient-Centric Paths to Improving Long-Term Outcomes

Therapeutic Advances in Immune Thrombocytopenia: Patient-Centric Paths to Improving Long-Term Outcomes

Partnering for Progress in AML: Practical Strategies for Collaborative Care

Partnering for Progress in AML: Practical Strategies for Collaborative Care

RSNA: Radiological Society of North America

More Evidence Backs AI-Supported Mammography

Interval cancer rates were noninferior versus standard double reading by radiologists

'Most Compelling' Data Yet for Metastasis-Directed Therapy in Prostate Cancer

But an association with improved overall survival failed to reach statistical significance

Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging

Stereotactic Radiation Better for Patients With Multiple Brain Metastases?

Symptom severity, interference with daily functioning were improved

First-of-Its-Kind Device for Pancreatic Cancer Wins FDA Approval

First approved therapy for locally advanced disease in almost three decades

Will AI Replace Physicians? Can Prior Auth Be Fixed? A Q&A With HHS's Health IT Czar

Thomas Keane talks about artificial intelligence and other challenges facing his agency